The Global Governance Of HIV/AIDS: Intellectual Property and Access to Essential Medicines

, ,

  • Obijiofor Aginam, John Harrington and Peter K. Yu

    ISBN-10: 1849804907,
    ISBN-13: 978-1849804905
    Edward Elgar Publishing
    June 2013

    This book explores the implications of high international intellectual property standards for access to essential medicines in developing countries. With a focus on HIV/AIDS governance, the volume provides a timely analysis of the international legal and political landscape, the relationship between human rights and intellectual property, and emerging issues in global health policy. It concludes with concrete strategies on how to improve access to HIV/AIDS medicines.

    About the Editors:

    Obijiofor Aginam is Senior Academic Officer at United Nations University Institute for Sustainability and Peace, Tokyo, Japan; John Harrington is Professor of Law at Cardiff University, Wales, UK; and Peter K. Yu is Kern Family Chair in Intellectual Property Law, Drake University Law School, US.

    Table of Contents:

    1. Introduction
    Obijiofor Aginam and John Harrington

    2. Communitarian Globalism and Disease: A Normative Orientation for Global Health Governance
    Obijiofor Aginam

    3. Is AIDS Treatment Sustainable?
    Kenneth C. Shadlen

    4. Access to Paediatric Medicines: The Global Political Economy of Drug Production and Supply for Children in the Developing World
    Avram Denburg and Kelley Lee

    5. Trade Agreements, Intellectual Property and Access to Essential Medicines: What Future Role for the Right to Health?
    James Harrison

    6. Re-visiting the Patents and Access to Medicines Dichotomy: An Evaluation of TRIPs Implementation and Public Health Safeguards in Developing Countries
    Tahir Amin

    7. Seizure of Generic Pharmaceuticals in Transit Based on Allegations of Patent Infringement: A Threat to International Trade, Development and Public Welfare
    Frederick M. Abbott

    8. Patent Licensing Strategies for the Research and Development of Pharmaceuticals in Developing Countries
    Gail E. Evans

    9. Increasing Access through Incentives for Innovation: The Health Impact Fund
    Laura Biron

    10. Building IPC4D to Promote Access to Essential Medicines
    Peter K. Yu

    11. The Global Governance of HIV/AIDS and the Rugged Road Ahead: An Epilogue
    Peter K. Yu